Page last updated: 2024-08-24

tsao-t and 1-(2',5'-bis-o-(tert-butyldimethylsilylribofuranosyl)-3-n-methylthymine)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)

tsao-t has been researched along with 1-(2',5'-bis-o-(tert-butyldimethylsilylribofuranosyl)-3-n-methylthymine)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (22.22)	18.2507
2000's	5 (55.56)	29.6817
2010's	2 (22.22)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balzarini, J; Camarasa, MJ; Hamamouch, N; San Félix, A; Sluis-Cremer, N; Velazquez, S	1
Balzarini, J; De Clercq, E; Marco-Contelles, J; Nguyen, VN; Pannecouque, C; Postel, D; Soriano, E; Tomassi, C	1
Arnold, E; Balzarini, J; Bauman, JD; Camarasa, MJ; Clark, AD; Das, K; Dharia, C; Rim, AS	1
Balzarini, J; Castelain, S; Duverlie, G; Fournier, C; Josse, S; Marco-Contelles, J; Moura, M; Nguyen Van Nhien, A; Postel, D; Soriano, E	1
Balzarini, J; Bohman, C; Camarasa, MJ; De Clercq, E; Naesens, L; Pérez-Pérez, MJ; San-Félix, A	1
Alvarez, R; Balzarini, J; Camarasa, MJ; Gago, F; Jimeno, ML; Pérez-Pérez, MJ	1
Aertsen, A; Balzarini, J; Camarasa, MJ; De Clercq, E; Pelemans, H; Pérez-Pérez, MJ; San-Félix, A; Van Laethem, K; Vandamme, AM; Velázquez, S	1
Anderson, JN; Balzarini, J; Camarasa, MJ; De Clercq, E; Karlsson, A; Pérez-Pérez, MJ; Perno, CF; San-Félix, A; Velázquez, S	1
Camarasa, MJ; Pérez-Pérez, MJ; San-Félix, A; Velázquez, S	1

Reviews

1 review(s) available for tsao-t and 1-(2',5'-bis-o-(tert-butyldimethylsilylribofuranosyl)-3-n-methylthymine)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)

Article	Year
TSAO derivatives the first non-peptide inhibitors of HIV-1 RT dimerization. Antiviral chemistry & chemotherapy, 2005, Volume: 16, Issue:3 Topics: Anti-HIV Agents; Dimerization; HIV Reverse Transcriptase; Humans; Organosilicon Compounds; Reverse Transcriptase Inhibitors; Spiro Compounds; Thymidine; Uridine	2005

Other Studies

8 other study(ies) available for tsao-t and 1-(2',5'-bis-o-(tert-butyldimethylsilylribofuranosyl)-3-n-methylthymine)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)

Article	Year
Structure-activity relationships of [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]- 3'-spiro-5' '-(4' '-amino-1' ',2' '-oxathiole-2' ',2' '-dioxide)thymine derivatives as inhibitors of HIV-1 reverse transcriptase dimerization. Journal of medicinal chemistry, 2006, Aug-10, Volume: 49, Issue:16 Topics: Anti-HIV Agents; Cell Line; Combinatorial Chemistry Techniques; Dimerization; HIV Reverse Transcriptase; HIV-1; Humans; Reverse Transcriptase Inhibitors; Spiro Compounds; Structure-Activity Relationship; Thymidine; Uridine	2006
Synthesis, anti-HIV-1 activity, and modeling studies of N-3 Boc TSAO compound. Bioorganic & medicinal chemistry letters, 2008, Apr-01, Volume: 18, Issue:7 Topics: Anti-HIV Agents; Binding Sites; Cell Line; HIV-1; HIV-2; Models, Chemical; Reverse Transcriptase Inhibitors; Spiro Compounds; Structure-Activity Relationship; Virus Replication	2008
Crystal structure of tert-butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in complex with HIV-1 reverse transcriptase (RT) redefines the elastic limits of the non-nucleoside inhibitor-binding pocket. Journal of medicinal chemistry, 2011, Apr-28, Volume: 54, Issue:8 Topics: Crystallography, X-Ray; Elasticity; HIV Reverse Transcriptase; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Reverse Transcriptase Inhibitors; Spiro Compounds; Structure-Activity Relationship; Thymidine; Uridine	2011
Synthesis and in vitro activity of novel N-3 acylated TSAO-T compounds against HIV-1 and HCV. European journal of medicinal chemistry, 2011, Volume: 46, Issue:10 Topics: Cell Line; Chemistry Techniques, Synthetic; Hepacivirus; Hepatitis C; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Reverse Transcriptase Inhibitors; Small Molecule Libraries; Spiro Compounds; Thymidine; Uridine	2011
Metabolism and pharmacokinetics of the anti-HIV-1-specific inhibitor [1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N- methyl-thymine]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dio xide). Biochemical pharmacology, 1993, Jul-06, Volume: 46, Issue:1 Topics: Animals; Antiviral Agents; CD4-Positive T-Lymphocytes; Cell Line; Half-Life; HIV-1; Humans; Metabolic Clearance Rate; Mice; Models, Chemical; Spiro Compounds; Thymidine; Thymidine Kinase; Thymidine Phosphorylase; Tissue Distribution; Tritium; Uridine	1993
Novel 3'-spiro nucleoside analogues of TSAO-T. Part II. A comparative study based on NMR conformational analysis in solution and theoretical calculations. Antiviral chemistry & chemotherapy, 1998, Volume: 9, Issue:4 Topics: Anti-HIV Agents; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Molecular Structure; Nucleosides; Reverse Transcriptase Inhibitors; Spiro Compounds; Static Electricity; Thymidine; Uridine	1998
Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138. Virology, 2001, Feb-01, Volume: 280, Issue:1 Topics: Alanine; Anti-HIV Agents; Aspartic Acid; Cell Line; Deoxyguanine Nucleotides; Dideoxynucleotides; DNA-Directed DNA Polymerase; Glutamic Acid; Glutamine; HIV Reverse Transcriptase; HIV-1; Humans; Lysine; Mutagenesis, Site-Directed; Nucleosides; Phenylalanine; Recombination, Genetic; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Spiro Compounds; Thymidine; Tyrosine; Uridine	2001
Exploitation of the low fidelity of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and the nucleotide composition bias in the HIV-1 genome to alter the drug resistance development of HIV. Journal of virology, 2001, Volume: 75, Issue:13 Topics: Anti-HIV Agents; Antimetabolites; Deoxycytosine Nucleotides; Drug Resistance, Microbial; Genome, Viral; HIV Reverse Transcriptase; HIV-1; Reverse Transcriptase Inhibitors; Spiro Compounds; Thymidine; Thymine Nucleotides; Uridine	2001